Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., MD (Medicine), FACP (USA)
Internal Medicine Specialist
Certified in Diabetology (USA), F.C.P.S (Medicine), M.B.B.S
Internal Medicine Specialist
Certified in Diabetology (USA), F.C.P.S (Medicine), M.B.B.S
Family Physician
MBBS (pak) , FCPS (pak) , MRCGP (UK), MRCS (UK), CCT (UK) , PG CERT, Diabetes (UK), MCFPC (Canada)
Family Physician
MBBS (pak) , FCPS (pak) , MRCGP (UK), MRCS (UK), CCT (UK) , PG CERT, Diabetes (UK), MCFPC (Canada)
Consultant Physician
MBBS, M.D Gastroenterology (Gold Medalist), FRCP (Gastroenterology & General Medicine)
Consultant Physician
MBBS, M.D Gastroenterology (Gold Medalist), FRCP (Gastroenterology & General Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine), CHPE
Internal Medicine Specialist
MBBS, MRCP-ll(UK)
Gastroenterologist
M.B.B.S., M.D (Gastro), MACG(America)
Dermatologist
M.B.B.S, M.R.C.P (UK)
Gastroenterologist
MBBS, FCPS, ESBGH (UK), SCE Gastro (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures